Abeona Therapeutics Announces Public Offering of Common Stock
16 oct. 2017 16h01 HE
|
Abeona Therapeutics Inc.
NEW YORK and CLEVELAND, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene and...
Abeona Therapeutics and Brammer Bio Announce Collaboration for Commercial Translation of ABO-102
28 sept. 2017 08h32 HE
|
Abeona Therapeutics Inc
--Strategic alignment with Brammer Bio for commercial AAV process development, scale up and assay validation --Phillip B. Maples, Ph.D., to lead Abeona manufacturing, as VP of Therapeutics...
Clinical Informatics News Best Practices Awards Opens for Entries
13 juin 2017 13h30 HE
|
Clinical Informatics News
NEEDHAM, MA--(Marketwired - June 13, 2017) - Clinical Informatics News, the leader in reporting innovative technologies from clinical trials to medical informatics, today opened the call for entries...
Bio-IT World Announces 2017 Best Practices Awards Winners
25 mai 2017 13h11 HE
|
Bio-IT World
NEEDHAM, MA--(Marketwired - May 25, 2017) - Bio-IT World has announced the winners of the 2017 Best Practices Awards this morning at the Bio-IT World Conference and Expo in Boston, MA. Entries from...
Abeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa
25 mai 2017 08h05 HE
|
Abeona Therapeutics Inc
Abeona’s Third Gene Therapy Program to Receive FDA Orphan Designation EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) has Demonstrated Promising Efficacy and Safety in...
Abeona Therapeutics Announces Top-Line Data for ABO-102 Phase 1/2 MPS IIIA Gene Therapy Trial at ASGCT
12 mai 2017 08h05 HE
|
Abeona Therapeutics Inc
--Positive dose response in central nervous system with 60.7% +/- 8.8% reduction of disease-causing heparan sulfate GAG observed in Cohort 2--Reduction of disease manifestation observed in decreased...
Abeona Therapeutics Receives Regulatory Approval to Initiate Clinical Trial in Australia with ABO-102 Gene Therapy For Patients with MPS IIIA
09 mai 2017 08h05 HE
|
Abeona Therapeutics Inc
NEW YORK and CLEVELAND, May 09, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for...
Association of Clinical Research Professionals (ACRP) and Barnett International (Barnett) Announce Training Partnership
27 avr. 2017 11h30 HE
|
Barnett International
WASHINGTON, DC and NEEDHAM, MA--(Marketwired - April 27, 2017) - The Association of Clinical Research Professionals (ACRP) and Barnett International (Barnett) today announced the formation of a...
Abeona Announces Rare Disease Gene Therapy Symposium with the New York Academy of Sciences
05 avr. 2017 07h43 HE
|
Abeona Therapeutics Inc
Company CEO to Co-Chair Symposium being held on April 11th in NYC NEW YORK and CLEVELAND, April 05, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage...
Winners of Clinical Informatics News' Best Practices Awards Announced in Miami
25 janv. 2017 15h00 HE
|
Clinical Informatics News
MIAMI, FL--(Marketwired - January 25, 2017) - Clinical Informatics News, the leader in reporting innovative technologies from clinical trials to medical informatics, announces the winners of the...